<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Psoriasis: News &amp; Videos about Psoriasis - CNN.com</title><link>http://topics.cnn.com/topics/feeds/rss/Psoriasis</link><description>Find stories, videos, and photos about Psoriasis from CNN.com.</description><language>en-us</language><copyright>Cable News Network LP, LLLP.</copyright><pubDate>Wed, 25 Nov 2009 10:51:27 GMT</pubDate><ttl>5</ttl><image><title>Psoriasis: News &amp; Videos about Psoriasis - CNN.com</title><url>http://i.cdn.turner.com//cnn/2009/HEALTH/02/20/raptiva.brain.infection/tztop.brain.nih.jpg</url><link>http://topics.cnn.com/topics/feeds/rss/Psoriasis</link><width>144</width><height>33</height><description>Find stories, videos, and photos about Psoriasis from CNN.com.</description></image><item><title>FDA: Psoriasis drug could cause deadly brain infection</title><link>http://www.cnn.com/2009/HEALTH/02/20/raptiva.brain.infection/index.html#cnnSTCText</link><guid>http://www.cnn.com/2009/HEALTH/02/20/raptiva.brain.infection/index.html#cnnSTCText</guid><description>The government is warning that taking the psoriasis drug Raptiva could result in serious brain infection and even death.</description><pubDate>Fri, 20 Feb 2009 17:39:00 EST</pubDate></item><item><title>LeAnn Rimes Recalls 'Scaly Girl' Kid Taunts</title><link>http://www.people.com/people/article/0,,20247941,00.html?xid=rss-fullcontentcnn</link><guid>http://www.people.com/people/article/0,,20247941,00.html?xid=rss-fullcontentcnn</guid><description>Others "didn't want to hang out with me or touch me," the singer says of her psoriasis</description><pubDate>Mon, 22 Dec 2008 17:52:00 EST</pubDate></item><item><title>LeAnn Rimes Discloses Her Struggle with Psoriasis</title><link>http://www.people.com/people/article/0,,20222836,00.html?xid=rss-fullcontentcnn</link><guid>http://www.people.com/people/article/0,,20222836,00.html?xid=rss-fullcontentcnn</guid><description>The singer shares her experience in a new PSA to raise awareness of the disease</description><pubDate>Wed, 03 Sep 2008 19:13:00 EDT</pubDate></item><item><title>Schering stock jumps on earnings win</title><link>http://money.cnn.com/2008/02/12/news/companies/schering/index.htm</link><guid>http://money.cnn.com/2008/02/12/news/companies/schering/index.htm</guid><description>Schering-Plough may have lost billions of dollars in the fourth quarter from an acquisition, but its stock jumped Tuesday as the drugmaker's earnings without charges beat expectations.</description><pubDate>Tue, 12 Feb 2008 17:00:00 EST</pubDate></item><item><title>Amgen earnings, sales beat forecast</title><link>http://money.cnn.com/2008/01/24/news/amgen/index.htm</link><guid>http://money.cnn.com/2008/01/24/news/amgen/index.htm</guid><description>Biotech Amgen on Thursday reported an increase in earnings and a decrease in sales for the fourth quarter, beating Wall Street's forecast.</description><pubDate>Thu, 24 Jan 2008 23:05:00 EST</pubDate></item><item><title>Abbott's quarterly results top estimates</title><link>http://money.cnn.com/2008/01/23/news/companies/abbott/index.htm</link><guid>http://money.cnn.com/2008/01/23/news/companies/abbott/index.htm</guid><description>Abbott Laboratories, a maker of drugs and medical devices, reported on Wednesday a jump in sales and earnings that beat Wall Street's estimates.</description><pubDate>Wed, 23 Jan 2008 15:20:00 EST</pubDate></item><item><title>FDA approves Abbott drug for psoriasis</title><link>http://money.cnn.com/2008/01/18/news/companies/abbott/index.htm</link><guid>http://money.cnn.com/2008/01/18/news/companies/abbott/index.htm</guid><description>The FDA approved Abbott's blockbuster drug Humira for yet another indication, psoriasis, the drugmaker said Friday.</description><pubDate>Fri, 18 Jan 2008 22:00:00 EST</pubDate></item><item><title>No single remedy fixes psoriasis</title><link>http://www.cnn.com/2007/HEALTH/conditions/08/13/hm.psoriasis/index.html#cnnSTCText</link><guid>http://www.cnn.com/2007/HEALTH/conditions/08/13/hm.psoriasis/index.html#cnnSTCText</guid><description>Psoriasis is an inflammatory skin condition that affects up to 5 million Americans. CNN learned more about psoriasis from Dr. Mathew Avram, director of the Massachusetts General Hospital Dermatology Laser and Cosmetics Center. </description><pubDate>Mon, 13 Aug 2007 02:10:00 EDT</pubDate></item><item><title>Amgen earnings meet forecasts</title><link>http://money.cnn.com/2007/04/23/news/companies/amgen/index.htm</link><guid>http://money.cnn.com/2007/04/23/news/companies/amgen/index.htm</guid><description>The biotech Amgen reported first-quarter earnings Monday that matched expectations, though its revenue fell just short of forecasts.</description><pubDate>Mon, 23 Apr 2007 20:11:00 EDT</pubDate></item><item><title>Congress said to want cheaper biotech drugs</title><link>http://money.cnn.com/2007/04/07/news/congress_biotechs/index.htm</link><guid>http://money.cnn.com/2007/04/07/news/congress_biotechs/index.htm</guid><description>Senior Democrats and Republicans in Congress are hard at work on bills that would provide millions of Americans with cheaper copies of biotech drugs that can cost hundreds of thousands of dollars a year, a news report said Saturday.</description><pubDate>Sun, 08 Apr 2007 00:44:00 EDT</pubDate></item><item><title>Abbott pitches Humira for psoriasis</title><link>http://money.cnn.com/2007/04/02/news/companies/abbott/index.htm</link><guid>http://money.cnn.com/2007/04/02/news/companies/abbott/index.htm</guid><description>Abbott Laboratories is trying to get its top-selling blockbuster drug approved for yet another use, which could lead to further sales.</description><pubDate>Mon, 02 Apr 2007 12:36:00 EDT</pubDate></item><item><title>Amgen reports surge in earnings, sales</title><link>http://money.cnn.com/2007/01/25/news/companies/amgen/index.htm</link><guid>http://money.cnn.com/2007/01/25/news/companies/amgen/index.htm</guid><description>A surge in Amgen Inc's fourth-quarter earnings fell short of analyst projections,  but the company's sales topped expectations.</description><pubDate>Thu, 25 Jan 2007 20:09:00 EST</pubDate></item><item><title>Abbott's Humira: More uses, more money</title><link>http://money.cnn.com/2006/08/31/news/companies/abbott/index.htm</link><guid>http://money.cnn.com/2006/08/31/news/companies/abbott/index.htm</guid><description>Abbott Labs' fast-growing flagship drug Humira is grabbing market share and making money ... and now the company is trying to win the blessings of the FDA to make more.</description><pubDate>Thu, 31 Aug 2006 17:26:00 EDT</pubDate></item><item><title>Amgen results don't cheer analysts</title><link>http://money.cnn.com/2006/04/18/news/companies/amgen/index.htm</link><guid>http://money.cnn.com/2006/04/18/news/companies/amgen/index.htm</guid><description>Amgen Inc., the world's biggest biotech developer, beat earnings expectations for the first quarter Tuesday, but analysts were still skeptical about the company's performance.</description><pubDate>Tue, 18 Apr 2006 21:40:00 EDT</pubDate></item><item><title>This week in the medical journals</title><link>http://www.cnn.com/2005/HEALTH/10/21/journal.roundup/index.html</link><guid>http://www.cnn.com/2005/HEALTH/10/21/journal.roundup/index.html</guid><description>Drug safety made headlines in the major medical journals this week when noted Cleveland Clinic cardiologists came up with a disturbing analysis about a new diabetes drug that is just a hair away from approval by the Food and Drug Administration.</description><pubDate>Fri, 21 Oct 2005 14:23:00 EDT</pubDate></item><item><title>Could Celebrex survive a black box?</title><link>http://money.cnn.com/2005/05/03/news/fortune500/blackbox/index.htm</link><guid>http://money.cnn.com/2005/05/03/news/fortune500/blackbox/index.htm</guid><description>The black box label is the most potent warning in the Food and Drug Administration's arsenal, but it is not necessarily a death knell for drug sales, analysts say.</description><pubDate>Tue, 03 May 2005 14:48:00 EDT</pubDate></item><item><title>Firm warns doctors of arthritis drug risk</title><link>http://www.cnn.com/2004/HEALTH/conditions/10/08/drug.warning/index.html</link><guid>http://www.cnn.com/2004/HEALTH/conditions/10/08/drug.warning/index.html</guid><description>Johnson &amp;amp; Johnson says its rheumatoid arthritis drug Remicade may put patients at higher risk for lymphoma, and the company is sending out warning letters to physicians.</description><pubDate>Fri, 08 Oct 2004 14:53:00 EDT</pubDate></item><item><title>Elite Factories</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2004/09/06/380337/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2004/09/06/380337/index.htm</guid><description>A common thread connects this year's standouts: They all responded to crisis by radically changing the way they make things. Autoliv reprocessed its factory to fend off stiff competition in airbags...</description><pubDate>Mon, 06 Sep 2004 04:01:00 EDT</pubDate></item><item><title>Growing Against The Grain Amgen CEO Kevin Sharer stands accused of remaking the world's biggest biotech company in the image of </title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2004/05/03/368529/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2004/05/03/368529/index.htm</guid><description>The Empire State ballroom at the Grand Hyatt Hotel in midtown Manhattan typically serves as the setting for the kind of stuffy, state-of-a-business luncheons that are more snooze inducing than buzz...</description><pubDate>Mon, 03 May 2004 04:01:00 EDT</pubDate></item><item><title>Blue Chip WINNERS &amp;amp; LOSERS Bigger may be             better--the 50 largest stocks account for more than half of            </title><link>http://money.cnn.com/magazines/moneymag/moneymag_archive/2002/06/01/323300/index.htm</link><guid>http://money.cnn.com/magazines/moneymag/moneymag_archive/2002/06/01/323300/index.htm</guid><description>The economy seems to be chugging back onto the right track, and Wall Street wisdom (no jokes, please) has stocks rising this year after two consecutive annual declines. But before you jump for joy,...</description><pubDate>Sat, 01 Jun 2002 04:01:00 EDT</pubDate></item><item><title>Biotech's New Colossus Move over, Big Pharma. Amgen             boasts better growth.</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2002/04/15/321395/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2002/04/15/321395/index.htm</guid><description>For years Amgen has seemed biotechnology's best answer to the likes of Merck--a sector leader with so much heft and momentum that you'd recommend its stock to your mom. But now making that analogy ...</description><pubDate>Mon, 15 Apr 2002 04:01:00 EDT</pubDate></item><item><title>Biotech Grows Up With real profits and a wave of new drugs, it's a sector few investors can ignore anymore.</title><link>http://money.cnn.com/magazines/moneymag/moneymag_archive/2002/03/01/319612/index.htm</link><guid>http://money.cnn.com/magazines/moneymag/moneymag_archive/2002/03/01/319612/index.htm</guid><description>The first wave in biotechnology investing arrived back in the late 1980s, when revolutionary new medicines created by pioneers like Amgen alerted investors to the fledgling sector's potential. The ...</description><pubDate>Fri, 01 Mar 2002 05:01:00 EST</pubDate></item><item><title>Finding The Bulls In Biotech The sector is blazing, the science ever more titillating. But with share prices up 214% in three ye</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2002/02/04/317524/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2002/02/04/317524/index.htm</guid><description>On Dec. 17, Amgen, the flagship company of the biotechnology world, closed the biggest merger in the sector's history. It agreed to pay $16 billion to buy rival Immunex, primarily for the right to ...</description><pubDate>Mon, 04 Feb 2002 05:01:00 EST</pubDate></item><item><title>U.S. Faces Protein Deficiency</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/2001/05/28/303868/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/2001/05/28/303868/index.htm</guid><description>Patients who want the rheumatoid arthritis-fighting drug Enbrel have to show a special card to their pharmacist, who then verifies that the patient is enrolled in the Enbrel program before dispensi...</description><pubDate>Mon, 28 May 2001 04:01:00 EDT</pubDate></item><item><title>Profile: Examine With Care Caution and research are the hallmarks of this doctor's style.</title><link>http://money.cnn.com/magazines/moneymag/moneymag_archive/1999/04/01/257677/index.htm</link><guid>http://money.cnn.com/magazines/moneymag/moneymag_archive/1999/04/01/257677/index.htm</guid><description>Like any good family practitioner, Dr. Reginald Parker believes in protecting against loss. So he begins his financial exams with some basic questions: What stocks do the mutual funds own? What ind...</description><pubDate>Thu, 01 Apr 1999 05:01:00 EST</pubDate></item><item><title>THE TICKER</title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1997/10/27/233326/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1997/10/27/233326/index.htm</guid><description>FREEING A MICROSOFT SLAVE </description><pubDate>Mon, 27 Oct 1997 05:01:00 EST</pubDate></item><item><title>RED LIGHT THAT STOPS CANCER A LASER-ACTIVATED DRUG             OFFERS SURGEONS A WAY TO ATTACK MALIGNANT TUMORS THEIR           </title><link>http://money.cnn.com/magazines/fortune/fortune_archive/1995/03/20/201969/index.htm</link><guid>http://money.cnn.com/magazines/fortune/fortune_archive/1995/03/20/201969/index.htm</guid><description>In a dimly lit operating room at the Thompson Cancer Survival Center in Knoxville, Tennessee, a surgeon uses an endoscope to guide an optical fiber down the throat of a patient afflicted with cance...</description><pubDate>Mon, 20 Mar 1995 05:01:00 EST</pubDate></item></channel></rss>